The hottest FDA Approval Substack posts right now

And their main takeaways
Top Finance Topics
The Last Bear Standing 43 implied HN points 15 Mar 24
  1. There has been a resurgence of interest in the medical potential of psychedelics, with ongoing research and clinical trials exploring their efficacy in treating mental health conditions.
  2. Despite the challenges and market fluctuations, there is increasing regulatory support for psychedelic drug trials, potentially leading to FDA approvals and breakthrough therapy designations for conditions like PTSD.
  3. Psychedelic treatments involve controlled drug administration in conjunction with therapy, aiming to address the root causes of mental health disorders by stimulating new perspectives and thought patterns.
COVID Reason 1493 implied HN points 31 Jul 23
  1. Remdesivir, a controversial drug, was approved by the FDA for COVID treatment in kidney patients.
  2. Family members of patients express anger and grief over the use of Remdesivir, linking it to worsened health conditions and deaths.
  3. Financial incentives and hospital protocols played a significant role in the administration of Remdesivir, raising concerns about ethics and patient care.
The PhilaVerse 123 implied HN points 30 Mar 23
  1. New FDA rules require medical device makers to meet specific cybersecurity criteria for approval.
  2. Manufacturers must offer updates and patches for cybersecurity and develop a plan for addressing postmarket vulnerabilities.
  3. Rules focus on devices connected to the internet, like insulin pumps and pacemakers, not legacy technology.
More is Different 3 implied HN points 22 Jan 24
  1. Cognitive Behavioral Therapy for Insomnia is the best first-line treatment for insomnia.
  2. Sleep medications can help with treatment-resistant insomnia but come with significant negative side effects and should not be used long term.
  3. Benadryl and doxylamine are common over-the-counter sleep aids with safety and efficacy concerns, potential for anticholinergic side effects and long-term safety issues.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
semaglutide 0 implied HN points 16 Nov 23
  1. Zepbound, a new weight loss drug, is approved by the FDA and competes with established drugs like Wegovy.
  2. Zepbound may lead to a price war in the weight loss drug market, potentially resulting in lower prices for consumers.
  3. Zepbound's unique combination of hormones helps with weight loss and Eli Lilly is already working on even more potent drugs in the future.